BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 10424676)

  • 1. Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment.
    Ruan RS; Leong SK; Mark I; Yeoh KH
    Neuroreport; 1999 Jul; 10(10):2067-71. PubMed ID: 10424676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration.
    Tan J; Wang Y; Yip X; Glynn F; Shepherd RK; Caruso F
    Adv Mater; 2012 Jul; 24(25):3362-6. PubMed ID: 22610659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and otoprotective strategies of programmed cell death on aminoglycoside-induced ototoxicity.
    Han L; Wang Z; Wang D; Gao Z; Hu S; Shi D; Shu Y
    Front Cell Dev Biol; 2023; 11():1305433. PubMed ID: 38259515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Signaling in BDNF-Treated Guinea Pigs after Ototoxic Deafening.
    Tisi A; Ramekers D; Flati V; Versnel H; Maccarone R
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates to the guinea pig animal model for in-vivo auditory neuroscience in the low-frequency hearing range.
    Montes-Lourido P; Kar M; Pernia M; Parida S; Sadagopan S
    Hear Res; 2022 Oct; 424():108603. PubMed ID: 36099806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Protective Effects of Hair Cells or Supporting Cells in Ototoxically Deafened Guinea Pigs upon Administration of BDNF.
    Tisi A; Rovers J; Vink HA; Ramekers D; Maccarone R; Versnel H
    Brain Sci; 2021 Dec; 12(1):. PubMed ID: 35053747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles-encapsulated brain-derived neurotrophic factor mRNA delivered through the round window niche in the cochleae of guinea pigs.
    Miwa T; Saito H; Akita H
    Exp Brain Res; 2021 Feb; 239(2):425-433. PubMed ID: 33215262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived nerve growth factor in the cochlea - a reproducibility study.
    Blakley BW; Seaman M; Alenezi A
    J Otolaryngol Head Neck Surg; 2020 Jun; 49(1):37. PubMed ID: 32503640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from noise-induced cochlear synaptopathy by virally mediated overexpression of NT3.
    Hashimoto K; Hickman TT; Suzuki J; Ji L; Kohrman DC; Corfas G; Liberman MC
    Sci Rep; 2019 Oct; 9(1):15362. PubMed ID: 31653916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otoprotective effects of mouse nerve growth factor in DBA/2J mice with early-onset progressive hearing loss.
    Wang Q; Zhao H; Zheng T; Wang W; Zhang X; Wang A; Li B; Wang Y; Zheng Q
    J Neurosci Res; 2017 Oct; 95(10):1937-1950. PubMed ID: 28345280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside Increases Permeability of Osseous Spiral Laminae of Cochlea by Interrupting MMP-2 and MMP-9 Balance.
    Li D; Sun J; Zhao L; Guo W; Sun W; Yang S
    Neurotox Res; 2017 Apr; 31(3):348-357. PubMed ID: 28005182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral-mediated Ntf3 overexpression disrupts innervation and hearing in nondeafened guinea pig cochleae.
    Lee MY; Kurioka T; Nelson MM; Prieskorn DM; Swiderski DL; Takada Y; Beyer LA; Raphael Y
    Mol Ther Methods Clin Dev; 2016; 3():16052. PubMed ID: 27525291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Round-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure.
    Suzuki J; Corfas G; Liberman MC
    Sci Rep; 2016 Apr; 6():24907. PubMed ID: 27108594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.
    Khalin I; Alyautdin R; Kocherga G; Bakar MA
    Int J Nanomedicine; 2015; 10():3245-67. PubMed ID: 25995632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of noise-induced hearing loss using methylene blue.
    Park JS; Jou I; Park SM
    Cell Death Dis; 2014 Apr; 5(4):e1200. PubMed ID: 24763057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability of long-term gene therapy in the cochlea.
    Atkinson PJ; Wise AK; Flynn BO; Nayagam BA; Richardson RT
    Sci Rep; 2014 Apr; 4():4733. PubMed ID: 24751795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.
    Huth ME; Ricci AJ; Cheng AG
    Int J Otolaryngol; 2011; 2011():937861. PubMed ID: 22121370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.
    Wise AK; Hume CR; Flynn BO; Jeelall YS; Suhr CL; Sgro BE; O'Leary SJ; Shepherd RK; Richardson RT
    Mol Ther; 2010 Jun; 18(6):1111-22. PubMed ID: 20216530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.
    Richardson RT; Wise AK; Thompson BC; Flynn BO; Atkinson PJ; Fretwell NJ; Fallon JB; Wallace GG; Shepherd RK; Clark GM; O'Leary SJ
    Biomaterials; 2009 May; 30(13):2614-24. PubMed ID: 19178943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase inhibitors promote vestibular hair cell survival and function after aminoglycoside treatment in vivo.
    Matsui JI; Haque A; Huss D; Messana EP; Alosi JA; Roberson DW; Cotanche DA; Dickman JD; Warchol ME
    J Neurosci; 2003 Jul; 23(14):6111-22. PubMed ID: 12853430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.